- Home
- OPAL vs ALGS Comparison
OPAL vs ALGS Comparison
Compare OPAL & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAL
- ALGS
- Stock Information
- Founded
- OPAL 1998
- ALGS 2018
- Country
- OPAL United States
- ALGS United States
- Employees
- OPAL N/A
- ALGS N/A
- Industry
- OPAL Natural Gas Distribution
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- OPAL Utilities
- ALGS Health Care
- Exchange
- OPAL Nasdaq
- ALGS Nasdaq
- Market Cap
- OPAL 65.5M
- ALGS 53.0M
- IPO Year
- OPAL N/A
- ALGS 2020
- Fundamental
- Price
- OPAL $2.12
- ALGS $10.20
- Analyst Decision
- OPAL Sell
- ALGS Strong Buy
- Analyst Count
- OPAL 4
- ALGS 2
- Target Price
- OPAL $2.81
- ALGS $60.00
- AVG Volume (30 Days)
- OPAL 111.6K
- ALGS 72.5K
- Earning Date
- OPAL 11-06-2025
- ALGS 11-05-2025
- Dividend Yield
- OPAL N/A
- ALGS N/A
- EPS Growth
- OPAL N/A
- ALGS N/A
- EPS
- OPAL 0.06
- ALGS N/A
- Revenue
- OPAL $329,933,000.00
- ALGS $3,174,000.00
- Revenue This Year
- OPAL $21.15
- ALGS N/A
- Revenue Next Year
- OPAL $18.76
- ALGS $28.79
- P/E Ratio
- OPAL $38.77
- ALGS N/A
- Revenue Growth
- OPAL 12.22
- ALGS N/A
- 52 Week Low
- OPAL $1.26
- ALGS $3.76
- 52 Week High
- OPAL $4.11
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- OPAL 37.47
- ALGS 52.79
- Support Level
- OPAL $2.08
- ALGS $10.66
- Resistance Level
- OPAL $2.24
- ALGS $11.65
- Average True Range (ATR)
- OPAL 0.11
- ALGS 0.84
- MACD
- OPAL -0.01
- ALGS -0.08
- Stochastic Oscillator
- OPAL 10.53
- ALGS 15.73
About OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.